PTPA and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, the sphingosine analog FTY720, which has been demonstrated to activate PP2A, was found to reduce cell proliferation and induce apoptosis in models of CML, as well as on the Kasumi-1 t(8;21) AML cell line [32, 33].